Literature DB >> 2606178

Prevalence of HBeAg, anti-HBe serological markers and HBV-DNA in asymptomatic carriers in Ethiopia.

M Rapicetta1, K Hailù, G Morace, L Bisanti, A M Di Rienzo, A R Ciccaglione, D Bekura, P Pasquini, G B Rossi.   

Abstract

Data on the distribution of HBV-DNA and other serological markers of hepatitis B virus infection in a population of asymptomatic carriers in Ethiopia are reported. As compared to data from other countries of similar or lower levels of endemicity, it has been found that HBV-DNA prevalence and its correlation with HBeAg/anti-HBe status is similar to that of northern Europe. HBV-DNA is present in 84% of HBe Ag-positive sera but in only 4% of anti-HBe-positive sera, where the lowest concentration of DNA (less than 5 pgr/20 microliters) was found. The trend of increasing prevalence of serological markers with age seems to indicate a considerable horizontal transmission still present in this age range (18-30). In keeping with data of other authors a 3% of HBV-DNA positivity in anti HBc only positive sera was found. No regional or ethnical differences of HBV-DNA positive sera across the country were observed. There is also no evidence of any correlation between HBV-DNA prevalence and HBsAg subtypes ad and ay.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606178     DOI: 10.1007/bf00140145

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  Clinical uses of HBV-DNA assays.

Authors:  H C Thomas; P Karayiannis; M J Fowler; J Monjardino
Journal:  J Virol Methods       Date:  1985-04       Impact factor: 2.014

2.  Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers.

Authors:  J Scotto; M Hadchouel; C Hery; J Yvart; P Tiollais; C Brechot
Journal:  Hepatology       Date:  1983 May-Jun       Impact factor: 17.425

3.  Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen.

Authors:  C Bréchot; F Degos; C Lugassy; V Thiers; S Zafrani; D Franco; H Bismuth; C Trépo; J P Benhamou; J Wands
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

4.  Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.

Authors:  S J Hadziyannis; H M Lieberman; G G Karvountzis; D A Shafritz
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

5.  Identification and transmission of hepatitis B virus-related variants.

Authors:  J R Wands; Y K Fujita; K J Isselbacher; C Degott; H Schellekens; M C Dazza; V Thiers; P Tiollais; C Brechot
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.

Authors:  C M Chu; P Karayiannis; M J Fowler; J Monjardino; Y F Liaw; H C Thomas
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

7.  Primary hepatocellular carcinoma and hepatitis B virus infection in Korea.

Authors:  W K Chung; H S Sun; D H Park; G Y Minuk; J H Hoofnagle
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

8.  Age-specific prevalence of hepatitis B e antigen (HBeAg) and antibody to HBeAg (anti-HBe) among asymptomatic hepatitis B surface antigen (HBsAg) carriers in Okinawa and Kyushu, Japan.

Authors:  S Kashiwagi; J Hayashi; H Nomura; W Kajiyama; H Ikematsu; T Shingu; K Hayashida; M Kaji
Journal:  Microbiol Immunol       Date:  1986       Impact factor: 1.955

9.  Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.

Authors:  Y F Liaw; C M Chu; D Y Lin; I S Sheen; C Y Yang; M J Huang
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

10.  Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.

Authors:  F Bonino; F Rosina; M Rizzetto; R Rizzi; E Chiaberge; R Tardanico; F Callea; G Verme
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

View more
  3 in total

1.  Familial pattern of infection with hepatitis B virus among immigrating Ethiopian Jews in Israel.

Authors:  N Bisharat; M Elias; R Raz; E Flatau
Journal:  Eur J Epidemiol       Date:  1998-01       Impact factor: 8.082

2.  Hepatitis B Virus Infection and Associated Factors Among Adults in Southwest Ethiopia: Community-Based Cross-Sectional Study.

Authors:  Alemayehu Sayih Belay; Dejene Derseh Abateneh; Sisay Shewasinad Yehualashet; Kindie Mitiku Kebede
Journal:  Int J Gen Med       Date:  2020-06-22

3.  Hepatitis viruses in Ethiopia: a systematic review and meta-analysis.

Authors:  Yeshambel Belyhun; Melanie Maier; Andargachew Mulu; Ermias Diro; Uwe Gerd Liebert
Journal:  BMC Infect Dis       Date:  2016-12-19       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.